Affimed (AFMD) Prices 12M Share Common Offering at $2.50/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ACCV
3. SPY
4. QQQ
5. AZN
6. FICO
7. SMMT
8. GMAB
9. SAIQ
10. IVBIY

Go back to Affimed (AFMD) Prices 12M Share Common Offering at $2.50/Sh

Affimed Announces Pricing of Public Offering of Common Shares

November 8, 2019 6:30 AM EST

Heidelberg, Germany, November 8, 2019 Affimed N.V. (Affimed or the Company) (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced the pricing of its previously announced public offering of 12,000,000 of its common shares at a public offering price of $2.50 per common share. In addition, Affimed has granted the underwriters a 30-day option to purchase up to an additional 1,800,000 common shares at the public offering price less underwriting discounts. After deducting the underwriting discounts, the net proceeds of the public offering are expected to be... More